Matinas BioPharma's total assets for Q2 2026 were $3.41M, a decrease of -41.91% from the previous quarter. DE:6LJ total liabilities were $1.61M for the fiscal quarter, a -43.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.